金凱生科(301509.SZ):重點開拓歐洲及亞太部分國家客户
格隆匯9月11日丨金凱生科(301509.SZ)在投資者關係活動上表示,公司已在積極主動調整,採取的主要應對措施包括:1.加強BD團隊力量,充分發揮國際化BD團隊及客户資源優勢,重點開拓歐洲及亞太部分國家客户,在爭取現有客户項目訂單的基礎上積極拓展業務增量;2.充分發揮美國GMP生產基地與研發中心的戰略支撐作用,在對沖風險的同時儘快讓該基地產生業績貢獻並導入更多項目;3.充分發揮醫藥CDMO領域的氟化技術優勢,以公司氟化特色技術為基礎,中短期內適當調配產能爭取非醫藥領域訂單,並尋求特殊含氟化學品領域一些新的增長點;4.加強研發投入和研發隊伍建設,加強公司特色產品的工藝優化和技術儲備,以控制和降低項目成本,並結合項目導入開展部分實驗室服務。以上的應對調整以公司長遠發展為根本目標,期望能夠儘快穩住公司業績並逐步走出低谷。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.